Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
63,800
-500 (-0.78%)
Aug 20, 2026, 3:30 PM KST

Mezzion Pharma Revenue

Mezzion Pharma had revenue of 2.02B KRW in the quarter ending March 31, 2026, with 3.19% growth. This brings the company's revenue in the last twelve months to 7.97B, down -5.18% year-over-year. In the year 2025, Mezzion Pharma had annual revenue of 7.91B, down -8.15%.

Revenue (ttm)
7.97B
Revenue Growth
-5.18%
P/S Ratio
244.95
Revenue / Employee
442.88M
Employees
18
Market Cap
1.95T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.91B-702.12M-8.15%
Dec 31, 20248.61B-23.11B-72.85%
Dec 31, 202331.72B994.76M3.24%
Dec 31, 202230.73B4.07B15.28%
Dec 31, 202126.65B-1.98B-6.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Samsung Biologics4.81T
Celltrion4.47T
Samsung Epis Holdings1.51T
Hugel479.57B
CLASSYS369.10B
ST Pharm346.22B
Celltrion Pharm274.73B
ALTEOGEN203.76B
Revenue Rankings